Search Results - "Stathias, V."

3O Pre-clinical pan-cancer drug repurposing via deep learning by Ocasio, B.A., Hu, J., Stathias, V., Martinez, M.J., Burnstein, K.L., Schurer, S.C.

Get full text

GE-32 AN INTERGRADED BIOINFORMATICS APPROACH FOR IDENTIFYING NOVEL GENE NETWORKS IN GLIOBLASTOMA by Stathias, V., Pastori, C., Komotar, R. J., Zhang, M., Clarke, J., Ayad, N. G.

“…Glioblastoma (GBM) is the most common and aggressive malignant brain tumor. Despite treatment advances, the median survival time is still below 2 years since…”
Get full text

CB-14 GENOMIC APPROACHES TO IDENTIFY CODING AND NONCODING RNA TARGETS IN MEDULLOBLASTOMA by Penas, C., Zhang, M., Clarke, J., Stathias, V., Roussel, M., Hatten, M., Ayad, N.

“…Medulloblastoma is the most common malignant pediatric brain tumor. Despite recent treatment advances, approximately 40% of children experience tumour…”
Get full text

EG-04 DEVELOPMENT OF HIGHLY POTENT, SELECTIVE BET BROMODOMAIN INHIBITORS THAT ARE CNS PENETRANT AND EFFECTIVE IN RODENT MODELS OF BRAIN CANCER by Johnstone, S., Johhnsone, A., Penas, C., Stathias, V., Brothers, S., Ayad, N., Wahlestedt, C., Albert, J.

“…BRD2, BRD3, and BRD4 are members of the BET family of bromodomain inhibitors that have received intense current interest as novel treatments for cancer. The…”
Get full text